Max-Delbrück Center for Molecular Medicine, 13125 Berlin, Germany.
J Biol Chem. 2012 Mar 9;287(11):8633-40. doi: 10.1074/jbc.M111.317644. Epub 2012 Jan 18.
In yeast, the membrane-bound HMG-CoA reductase degradation (HRD) ubiquitin-ligase complex is a key player of the ER-associated protein degradation pathway that targets misfolded proteins for proteolysis. Yos9, a component of the luminal submodule of the ligase, scans proteins for specific oligosaccharide modifications, which constitute a critical determinant of the degradation signal. Here, we report the crystal structure of the Yos9 domain that was previously suggested to confer binding to Hrd3, another component of the HRD complex. We observe an αβ-roll domain architecture and a dimeric assembly which are confirmed by analytical ultracentrifugation of both the crystallized domain and full-length Yos9. Our binding studies indicate that, instead of this domain, the N-terminal part of Yos9 including the mannose 6-phosphate receptor homology domain mediates the association with Hrd3 in vitro. Our results support the model of a dimeric state of the HRD complex and provide first-time evidence of self-association on its luminal side.
在酵母中,膜结合的 HMG-CoA 还原酶降解(HRD)泛素连接酶复合物是内质网相关蛋白降解途径的关键因子,该途径将错误折叠的蛋白质靶向进行蛋白酶体降解。Yos9 是连接酶腔亚基的一个组成部分,它可识别蛋白质上特定的寡糖修饰,这些修饰是降解信号的关键决定因素。在这里,我们报告了之前被认为与 HRD 复合物的另一个组成部分 Hrd3 结合的 Yos9 结构域的晶体结构。我们观察到一个 αβ-roll 结构域架构和二聚体组装,这通过结晶结构域和全长 Yos9 的分析超速离心得到了证实。我们的结合研究表明,与该结构域相反,Yos9 的 N 端部分包括甘露糖 6-磷酸受体同源结构域介导了其与 Hrd3 的体外结合。我们的结果支持 HRD 复合物二聚体状态的模型,并首次提供了其腔侧自身缔合的证据。